Imaging

Current and future role of tau-PET in dementia daily practice

Longitudinal clinical outcomes of tau-PET-positive individuals

Limitations of [18F]flortaucipir tau-PET imaging

Next generation tau tracers: [18F]MK-6420 vs [18F]flortaucipir

Associations between predicted brain age and Alzheimer’s Disease biomarkers

Can biomarkers help to predict brain age?

Use of machine learning in Alzheimer’s disease

APOEε4 carriership combined with Aβ positivity for AD clinical trial enrichment

Plasma versus neuroimaging biomarkers for Alzheimer’s disease clinical trials

Successful Aging after Elective Surgery: goals of the SAGES II study

The promise of reactive astrocytes as biomarkers

MBI associated with decreased connectivity in networks linked with Alzheimer’s disease

Early predictive value of plasma biomarkers for amyloid positivity

Blood biomarkers in Alzheimer’s disease: appropriate use recommendations

Aducanumab updated monitoring recommendations for amyloid-related imaging abnormalities (ARIA)

Biomarkers of apathy in Alzheimer’s disease